Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019)

Adaptive Biotechnologies' (ADPT) quarterly Other financing activities came in at $1.6 million in Q3 2019, up 12407.69% year-on-year from N/an in Q3 2018, and down 51.69% quarter-over-quarter from $3.4 million in Q2 2019.

Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019) Analysis & Trends

Adaptive Biotechnologies has disclosed Other financing activities across 2 years of filings, most recently posting $1.6 million for Q3 2019.

  • Other financing activities for Q3 2019 came in at $1.6 million, up 12407.69% year-over-year; the trailing twelve-month figure through Dec 2020 was $5.0 million (changed 0.12% YoY), and the FY2020 annual result was $321000.0, down 93.56% from the prior year.
  • Other financing activities came in at $1.6 million for Q3 2019 at Adaptive Biotechnologies, down from $3.4 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.4 million in Q2 2019 to a low of -$23000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Adaptive Biotechnologies 2.60 Bn 2.39 Bn 52.17 Mn

Historic Data

Download Data
DateValue
Sep 30, 2019 1.63 Mn
Sep 30, 2019 1.63 Mn
Jun 30, 2019 3.37 Mn
Jun 30, 2019 3.37 Mn
Mar 31, 2019 -6,000.00
Mar 31, 2019 -6,000.00
Dec 31, 2018 -23,000.00
Dec 31, 2018 -23,000.00
Sep 30, 2018 13,000.00
Sep 30, 2018 13,000.00
Jun 30, 2018 1,000.00
Jun 30, 2018 1,000.00